| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 519,841 | 455,894 | 538,445 | 444,273 | | Cost of Revenue | 291,431 | 266,758 | 312,885 | 256,680 | | | Gross Profit | 228,410 | 189,136 | 225,560 | 187,593 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 166,668 | 145,598 | 158,756 | 166,190 | | Non Recurring | (1,131) | 594 | 537 | 31,644 | | Others | 2,187 | 2,242 | 2,127 | 2,107 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,686 | 40,702 | 64,140 | (12,348) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (565) | (2,383) | 812 | 1,743 | | Earnings Before Interest And Taxes | 60,121 | 38,319 | 64,952 | (10,605) | | Interest Expense | 5,899 | 5,799 | 6,069 | 6,190 | | Income Before Tax | 54,222 | 32,520 | 58,883 | (16,795) | | Income Tax Expense | 21,344 | 13,199 | 20,134 | (4,747) | | Minority Interest | (2,500) |
-
|
-
| (621) | | | | Net Income From Continuing Ops | 30,378 | 19,321 | 38,749 | (12,669) | | | Non-recurring Events | | Discontinued Operations | (1,892) | (649) | (920) | (3,661) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,486 | 18,672 | 37,829 | (16,330) | | Preferred Stock And Other Adjustments | 1,170 | (912) | (258) |
-
| | | Net Income Applicable To Common Shares | $29,656 | $17,760 | $37,571 | ($16,330) |
|
0.37% Nasdaq 
Income Statement
